PHILADELPHIA and VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care announced today that the Company’s board of directors has approved the consolidation (the “Consolidation”) of the Company’s issued and outstanding common shares (the “Common Shares”) on the basis of one (1) post-Consolidation Common Share for every ten (10) pre-Consolidation Common Shares. The Consolidation is being implemented to ensure that the Company continues to comply with the listing requirements of The Nasdaq Capital Market (the “Nasdaq”).
Dr. Aarti Dhupelia joins fast-growing Chicago-based nonprofit as demand for its research-backed student support accelerates nationwide
CHICAGO, Aug. 5, 2025 /PRNewswire/ -- One Million Degrees...
NEWARK, N.J., Aug. 5, 2025 /PRNewswire/ -- New Jersey Innovation Institute (NJII), a subsidiary of the New Jersey Institute of Technology (NJIT), is pleased...
Iconic baseball brand to release limited-edition gloves to raise funds for the Saint Louis Zoo Association
ST. LOUIS, Mo., Aug. 5, 2025 /PRNewswire/ --...
DURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Open Invention Network (OIN), the only institution focused on mitigating patent risk in open source software, announced today that Midea Group has joined as a community member. As one of the world's leading smart home appliance brands, Midea is reinforcing its commitment to open source as an enabler of advanced, intelligent appliance platforms.